Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.77 USD | -0.43% | -18.26% | -41.33% |
May. 23 | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
May. 23 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- MarketScreener Strategies